<DOC>
	<DOCNO>NCT01854125</DOCNO>
	<brief_summary>Liver cirrhosis ( LC ) final destiny chronic liver disease.The quality life liver cirrhosis patient refractory ascites wretched . The objective study evaluate therapeutic efficacy autologous bone marrow mesenchymal stem cell ( BMSCs ) transplantation via liver artery Child-Pugh B C stage liver cirrhosis patient refractory ascites . The immunomodulatory impact MSCs fibrosis confirm , several clinical study apply MSCs eliminate progression fibrosis . In research investigator study affect influence MSCs patient , include assay liver function , variation ascites , Child-Pugh score etc .</brief_summary>
	<brief_title>Autologous Mesenchymal Stem Cell Transplantation Cirrhosis Patients With Refractory Ascites</brief_title>
	<detailed_description />
	<mesh_term>Ascites</mesh_term>
	<criteria>Aged 18~65 year . Ultrasonographic evidence cirrhosis . hepatic cirrhosis patient refractory ascite . history moderate severe hepatic encephalopathy variceal bleed last two month enrolment . Prothrombin time less 30 . Severe problem vital organ ( e.g.the heart , renal lung ) . Liver tumor ultrasonography , CT MRI examination . Pregnant lactating woman . Imaging evidence vascular thromboses .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>immun function</keyword>
	<keyword>liver function</keyword>
	<keyword>ascites</keyword>
	<keyword>quality life</keyword>
	<keyword>Child-Pugh score</keyword>
</DOC>